The effect of increasing nucleotide-sugar concentrations on the incorporation of sugars into glycoconjugates in rat hepatocytes
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Treatment of rat hepatocytes with 0.5 mM concentrations of uridine and cytidine results in increased cellular concentrations of UTP, UDP-sugars and CTP, whereas that of CMP-N-acetylneuraminate remained unchanged [Pels Rijcken, Overdijk, Van den Eijnden and Ferwerda (1993) Biochem. J. 293, 207-213]. The incorporation of radioactivity from 3H-labelled sugars into the cell-associated and secreted glycoconjugate fraction was influenced by these altered cellular concentrations of the nucleotides. For [3H]glucosamine, pretreatment with uridine resulted in a reduction of the glycosylation in both fractions. Increases in the secreted fractions were observed for fucose with both uridine and cytidine and for N-acetylglucosamine with uridine only. With [3H]N-acetylglucosamine, similar specific radioactivities for UDP-N-acetylhexosamine and CMP-N-acetylneuraminate were found, regardless of the pretreatment conditions. With [3H]N-acetylmannosamine, the specific radioactivity of CMP-N-acetylneuraminate showed an almost 2-fold increase on pretreatment. The latter increase did not result in an increased incorporation of radioactivity into the glycoconjugates. It was estimated that, in untreated cells, the ratio of radioactivity incorporated from [3H]glucosamine into glycoconjugate-bound N-acetylhexosamine and N-acetylneuraminate amounted to 2:3. In pretreated cells this ratio changed to approx. 2:1. Overall, the data show that pretreatment resulted in an increased incorporation of N-acetylhexosamine into cell-associated and secreted glycoconjugates, accompanied by a reduction in sialylation. It was concluded that an increased availability of UDP-N-acetylhexosamine caused the increased incorporation of N-acetylhexosamine. The elevated cytosolic level of UDP-N-acetylhexosamine (and of compounds like CMP) is suggested to impair the transport of CMP-acetylneuraminate to the Golgi, resulting in reduced sialylation. This study demonstrates that protein glycosylation can be regulated at the level of the availability of the various nucleotide-sugars in the Golgi lumen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schachter, H. (1986) · Biochemistry and Cell Biology · doi:10.1139/o86-026 · Cited by 526
Cited by
Getting the glycosylation right: Implications for the biotechnology industry
Jenkins, N., Parekh, R. B., & James, D. C. (1996) · Nature Biotechnology · doi:10.1038/nbt0896-975 · Cited by 458
Hirschberg, C. B., Robbins, P. W., & Abeijon, C. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.49 · Cited by 386
Tomiya, N., Ailor, E., Lawrence, S. M., Betenbaugh, M. J., & Lee, Y. C. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5091 · Cited by 203
Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose
Gramer, M. J., Eckblad, J. J., Donahue, R., Brown, J., Shultz, C., Vickerman, K., Priem, P., van den Bremer, E. T. J., Gerritsen, J., & van Berkel, P. H. C. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23075 · Cited by 193
Metabolic control of recombinant protein N‐glycan processing in NS0 and CHO cells
Baker, K. N., Rendall, M. H., Hills, A. E., Hoare, M., Freedman, R. B., & James, D. C. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1051 · Cited by 184
Determinants of Glycosaminoglycan (GAG) Structure
Prydz, K. (2015) · Biomolecules · doi:10.3390/biom5032003 · Cited by 173
“The import of substrate seems to be a rate limiting step, since additional expression of PAPS transporters [90] enhances PAPS uptake and the subsequent utilization, while an increase in the availability of UDP-N-acetylhexosamine (UDP-GlcNAc and -GalNAc), lead to enhancement of the incorporation into glycoconjugates [1…”
BackgroundJimenez del Val, I., Nagy, J. M., & Kontoravdi, C. (2011) · Biotechnology Progress · doi:10.1002/btpr.688 · Cited by 135
Metabolic control of recombinant monoclonal antibody N‐glycosylation in GS‐NS0 cells
Hills, A. E., Patel, A., Boyd, P., & James, D. C. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.10022 · Cited by 127
Jedrzejewski, P., Del Val, I., Constantinou, A., Dell, A., Haslam, S., Polizzi, K., & Kontoravdi, C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034492 · Cited by 83
Lin, N., Mascarenhas, J., Sealover, N. R., George, H. J., Brooks, J., Kayser, K. J., Gau, B., Yasa, I., Azadi, P., & Archer‐Hartmann, S. (2015) · Biotechnology Progress · doi:10.1002/btpr.2038 · Cited by 73
“mechanisms based on concentrations of CMP-sialic acid or UDP-GlcNAc.(39,41) The net increase in sialic acid content”
BackgroundOnitsuka, M., Kim, W.-D., Ozaki, H., Kawaguchi, A., Honda, K., Kajiura, H., Fujiyama, K., Asano, R., Kumagai, I., Ohtake, H., et al. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3814-1 · Cited by 48
Blondeel, E. J. M., & Aucoin, M. G. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.06.008 · Cited by 46
Sou, S. N., Jedrzejewski, P. M., Lee, K., Sellick, C., Polizzi, K. M., & Kontoravdi, C. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26225 · Cited by 45
“In addition, owing to the competitive inhibition of the CMP-Neu5Ac Golgi transporter protein in the presence of UDP-GlcNAc (Pels Rijcken et al., 1995), a transport inhibition term K i;CMPNeu5Ac;UDPGlcNAc is included in the material balance for the rate of CMP-Neu5Ac transport, which is defined in…”
Background
Metadata
- Authors
- Pels Rijcken, W. R., Overdijk, B., Van den Eijnden, D. H., & Ferwerda, W.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1995-02-01
- Volume
- 305
- Issue
- 3
- Pages
- 865-870
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2200227738
- Cited by
- 90
- References
- 1
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.